Validation data from https://doi.org/10.1039/C8SC04228D
Validation data from https://doi.org/10.1039/C8SC04228D · 10.1039/C8SC04228D
查看条件与参与物IDENTITY
COMPUTED
GHS
Warning
H302 (93%): Harmful if swallowed [Warning Acute toxicity, oral];H315 (11.6%): Causes skin irritation [Warning Skin corrosion/irritation];H319 (100%): Causes serious eye irritation [Warning Serious eye damage/eye irritation]
P264, P264+P265, P270, P280, P301+P317, P302+P352, P305+P351+P338, P321, P330, P332+P317, P337+P317, P362+P364, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 43 reports by companies from 6 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.;Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website.
HAZARDS
Acute Tox. 4 (93%);Skin Irrit. 2 (11.6%);Eye Irrit. 2A (100%)
PHARMACOLOGY
Agents used in the treatment of malaria. They are usually classified on the basis of their action against plasmodia at different stages in their life cycle in the human. (From AMA, Drug Evaluations Annual, 1992, p1585)
ALIASES
REACTIONS
Validation data from https://doi.org/10.1039/C8SC04228D
Validation data from https://doi.org/10.1039/C8SC04228D · 10.1039/C8SC04228D
查看条件与参与物Validation data from https://doi.org/10.1039/C8SC04228D
Validation data from https://doi.org/10.1039/C8SC04228D · 10.1039/C8SC04228D
查看条件与参与物Training data from https://doi.org/10.1039/C8SC04228D (7/10)
Training data from https://doi.org/10.1039/C8SC04228D (7/10) · 10.1039/C8SC04228D
查看条件与参与物Training data from https://doi.org/10.1039/C8SC04228D (5/10)
Training data from https://doi.org/10.1039/C8SC04228D (5/10) · 10.1039/C8SC04228D
查看条件与参与物uspto-grants-2002_01
uspto-grants-2002_01 · 10.6084/m9.figshare.5104873.v1 · US06337338B1
查看条件与参与物Training data from https://doi.org/10.1039/C8SC04228D (1/10)
Training data from https://doi.org/10.1039/C8SC04228D (1/10) · 10.1039/C8SC04228D
查看条件与参与物uspto-grants-2015_10
uspto-grants-2015_10 · 10.6084/m9.figshare.5104873.v1 · US09150519B2
查看条件与参与物uspto-grants-2015_10
uspto-grants-2015_10 · 10.6084/m9.figshare.5104873.v1 · US09150519B2
查看条件与参与物